Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
14.9M
-
Shares change
-
+627K
-
Total reported value, excl. options
-
$89.6M
-
Value change
-
+$3.77M
-
Number of buys
-
15
-
Number of sells
-
-30
-
Price
-
$6.00
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2017
65 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q2 2017.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.9M shares
of 386M outstanding shares and own 3.87% of the company stock.
Largest 10 shareholders include Paradice Investment Management LLC (1.64M shares), HEARTLAND ADVISORS INC (1.57M shares), JANUS HENDERSON GROUP PLC (1.41M shares), Lapides Asset Management, LLC (1.29M shares), Boston Partners (1.16M shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (1.08M shares), 22NW, LP (874K shares), STONEHILL CAPITAL MANAGEMENT LLC (739K shares), Senvest Management, LLC (714K shares), and HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (600K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.